0.00Open0.00Pre Close0 Volume0 Open Interest30.00Strike Price0.00Turnover203.04%IV-98.68%PremiumDec 20, 2024Expiry Date14.90Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8951Delta0.0270Gamma1.00Leverage Ratio-0.0304Theta-0.0102Rho-0.89Eff Leverage0.0063Vega
Wave Life Sciences Stock Discussion
Wave Life Sciences Announces First-Ever Therapeutic Rna Editing in Humans Achieved in Restoraation-2 Trial of Wve-006 in Alpha-1 Antitrypsin Deficiency
Wave Life Sciences Ltd: Expects to Share Multidose Data From Restoraation-2 Trial in 2025
In a notable transaction, GSK (LON:GSK) plc, a major player in the pharmaceutical industry, has recently increased its stake in Wave Life Sciences Ltd . (NASDAQ:WVE). The acquisition involved the purchase of 2,791,930 ordinary shares at a price of $8.00 per share, amounting to a total investment of $22.3 million.
This strategic move by GSK plc, which is known for its diverse portfolio of healthca...
No comment yet